U.S. market Closed. Opens in 1 day 8 hours 55 minutes

ADCT | ADC Therapeutics SA Stock Financials Income Statements Annual

(Stock Exchange: NYSE)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
Revenue69.56M209.91M33.92MN/A2.34M1.14M1.80M
Cost of Revenue2.53M4.58M1.39M1.97M107.54M118.09M85.53M
Gross Profit67.03M205.33M32.52M-1.97M-105.20M-116.95M-83.73M
Operating Expenses233.01M328.96M294.24M219.26M121.74M127.08M93.47M
Selling, General & Admin105.89M141.06M136.24M77.23M13.81M8.60M7.81M
Research & Development127.13M187.90M158.00M142.03M107.54M118.31M85.53M
Other Operating ExpensesN/A14.58M28.49M-46.40M388.00K166.00K137.00K
Operating Income-165.99M-123.63M-261.72M-219.26M-119.40M-125.94M-91.67M
Other Expenses / Income-29.43M-33.56M10.21M-26.70M3.50M3.07M1.86M
Before Tax Income-195.42M-154.66M-251.50M-245.96M-115.90M-122.87M-89.81M
Income Tax Expenses39.11M1.14M-21.48M327.00K582.00K224.00K48.00K
Net Income-240.05M-155.80M-230.03M-246.29M-116.48M-123.10M-89.86M
Interest Expenses46.33M36.92M18.34M4.93M156.00KN/AN/A
Basic Shares Outstanding81.71M78.15M76.75M65.41M66.87M53.83M58.85M
Diluted Shares Outstanding81.71M78.15M76.75M65.41M66.87M53.83M58.85M
EBITDA-146.76M-108.06M-223.72M-219.26M-114.10M-122.36M-91.33M
EBITDA Margin-210.99%-51.48%-659.60%0.00%-4,876.07%-10,733.25%-5,065.39%
EBIT-154.62M-117.74M-233.16M-241.04M-115.75M-122.87M-89.81M
EBIT Margin-222.29%-56.09%-687.46%0.00%-4,946.41%-10,778.25%-4,981.36%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙